These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 1498098

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1).
    Nakamura E, Miyamura Y, Matsunaga J, Kano Y, Dakeishi-Hara M, Tanita M, Kono M, Tomita Y.
    J Dermatol Sci; 2002 Feb; 28(2):102-5. PubMed ID: 11858948
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. R278TER and P431L mutations of the tyrosinase gene exist in Japanese patients with tyrosinase-negative oculocutaneous albinism.
    Matsunaga J, Dakeishi M, Shimizu H, Tomita Y.
    J Dermatol Sci; 1996 Nov; 13(2):134-9. PubMed ID: 8953413
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sequence-based diagnosis of tyrosinase-related oculocutaneous albinism: successful sequence analysis of the tyrosinase gene from blood spots dried on filter paper.
    Matsunaga J, Dakeishi-Hara M, Miyamura Y, Nakamura E, Tanita M, Satomura K, Tomita Y.
    Dermatology; 1998 Nov; 196(2):189-93. PubMed ID: 9568405
    [Abstract] [Full Text] [Related]

  • 7. Sequence analysis of the human tyrosinase promoter from a patient with tyrosinase-negative oculocutaneous albinism.
    Matsunaga J, Dakeishi M, Miyamura Y, Tomita Y.
    Pigment Cell Res; 1997 Nov; 10(1-2):64-7. PubMed ID: 9170165
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A dinucleotide deletion (-delta GA115) in the tyrosinase gene responsible for type I-A (tyrosinase negative) oculocutaneous albinism in a Pakistani individual.
    Oetting WS, Fryer JP, King RA.
    Hum Mol Genet; 1993 Jul; 2(7):1047-8. PubMed ID: 8364542
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Human oculocutaneous albinism. From clinical observation to molecular biology].
    Aquaron R.
    Bull Soc Pathol Exot; 1993 Jul; 86(5):313-26. PubMed ID: 8124097
    [Abstract] [Full Text] [Related]

  • 12. Molecular basis of type IA (tyrosinase negative) oculocutaneous albinism.
    King RA, Oetting WS.
    Pigment Cell Res; 1992 Jul; Suppl 2():249-53. PubMed ID: 1409426
    [Abstract] [Full Text] [Related]

  • 13. Sequence analysis of tyrosinase gene in ocular and oculocutaneous albinism patients: introducing three novel mutations.
    Khordadpoor-Deilamani F, Akbari MT, Karimipoor M, Javadi G.
    Mol Vis; 2015 Jul; 21():730-5. PubMed ID: 26167114
    [Abstract] [Full Text] [Related]

  • 14. Molecular bases of tyrosinase-negative oculocutaneous albinism: a single base insertion or a missense point mutation in the tyrosinase gene.
    Tomita Y, Takeda A, Matsunaga J, Okinaga S, Shibahara S, Tagami H.
    Pigment Cell Res; 1992 Jul; Suppl 2():96-100. PubMed ID: 1409445
    [Abstract] [Full Text] [Related]

  • 15. A tyrosinase gene missense mutation in temperature-sensitive type I oculocutaneous albinism. A human homologue to the Siamese cat and the Himalayan mouse.
    Giebel LB, Tripathi RK, King RA, Spritz RA.
    J Clin Invest; 1991 Mar; 87(3):1119-22. PubMed ID: 1900309
    [Abstract] [Full Text] [Related]

  • 16. Electron microscopic DOPA reaction test for oculocutaneous albinism.
    Takizawa Y, Kato S, Matsunaga J, Aozaki R, Tomita Y, Nishikawa T, Shimizu H.
    Arch Dermatol Res; 2000 Jun; 292(6):301-5. PubMed ID: 10929771
    [Abstract] [Full Text] [Related]

  • 17. The tyrosinase gene and oculocutaneous albinism type 1 (OCA1): A model for understanding the molecular biology of melanin formation.
    Oetting WS.
    Pigment Cell Res; 2000 Oct; 13(5):320-5. PubMed ID: 11041207
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Coexpression of wild-type tyrosinase enhances maturation of temperature-sensitive tyrosinase mutants.
    Halaban R, Cheng E, Hebert DN.
    J Invest Dermatol; 2002 Aug; 119(2):481-8. PubMed ID: 12190874
    [Abstract] [Full Text] [Related]

  • 20. Analysis of tyrosinase mutations associated with tyrosinase-related oculocutaneous albinism (OCA1).
    Oetting WS, King RA.
    Pigment Cell Res; 1994 Oct; 7(5):285-90. PubMed ID: 7886000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.